Endothelin receptor antagonists in pulmonary arterial hypertension
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (12), S62-S67
- https://doi.org/10.1016/j.jacc.2004.02.042
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertensionJournal of the American College of Cardiology, 2003
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- Endothelin-A-Receptors in Human Aorta and Pulmonary Arteries are Downregulated in Patients With Cardiovascular DiseaseJournal of Cardiovascular Pharmacology, 2000
- Activation of three types of voltage‐independent Ca2+ channel in A7r5 cells by endothelin‐1 as revealed by a novel Ca2+ channel blocker LOE 908British Journal of Pharmacology, 1999
- Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studiesCurrent Opinion in Nephrology and Hypertension, 1995
- Possible Role of Endothelin in Endothelial Regulation of Vascular ToneAnnual Review of Pharmacology and Toxicology, 1995
- Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells.Stroke, 1991
- Endothelin-1 release from lamb ductus arteriosus; relevance to postnatal closure of the vesselCanadian Journal of Physiology and Pharmacology, 1991
- Antiaggregatory and Hypotensive Effects of Endothelin-1 in Beagle DogsJournal of Cardiovascular Pharmacology, 1991
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990